Clinical Trial Update: Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update examines ketamine hydrochloride for improving pain management in cancer patients with neuropathic pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Neuropathic Pain

Drugs mentioned

• Ketamine hydrochloride (Ketamine hydrochloride)

Snippet

Sponsor: University of Glasgow | Conditions: Cancer | Phase 3 | Status: UNKNOWN